Objective: To determine the frequency and predictors of cardiac stress testing before elective noncardiac surgery in Medicare patients with no indications for cardiovascular evaluation. Background: The American College of Cardiology/American Heart Association guidelines indicate that patients without class I (American Heart Association high risk) or class II cardiac conditions (clinical risk factors) should not undergo cardiac stress testing before elective noncardiac, nonvascular surgery. Methods: We used 5% Medicare inpatient claims data (1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008) to identify patients aged ≥ 66 years who underwent elective general surgical, urological, or orthopedic procedures (N = 211,202). We examined the use of preoperative stress testing in the subset of patients with no diagnoses consistent with cardiac disease (N = 74,785). Bivariate and multivariate analyses were used to identify predictors of preoperative cardiac stress testing. Results: Of the patients with no cardiac indications for preoperative stress testing, 3.75% (N = 2803) received stress testing in the 2 months before surgery. The rate of preoperative stress testing increased from 1.72% in 1996 to 6.44% in 2007 (P < 0.0001). A multivariate analysis adjusting for patient and hospital characteristics showed a significant increase in preoperative stress testing over time. Female sex [odds ratio (OR) 1.11; 95% CI: 1.02-1.21], presence of other comorbidities [OR 1.22; 95% confidence interval (CI): 1.09-1.35], high-risk procedure (OR 2.42; 95% CI: 2.04-2.89), and larger hospital size (OR 1.17; 95% CI: 1.03-1.32) were positive predictors of stress testing. Patients living in regions with greater Medicare expenditures (OR 1.24; 95% CI: 1.05-1.45) were also more likely to receive stress tests.
In 2007, the American College of Cardiology and the American Heart Association Task Force on Practice Guidelines published current guidelines regarding preoperative cardiovascular evaluation for individuals undergoing noncardiac surgery. 1 The Task Force classified noncardiac surgical procedures into the following categories based on incidence of cardiac death and nonfatal myocardial infarction: vascular (cardiac risk > 5%), intermediate risk (cardiac risk 1%-5%), and low risk (cardiac risk < 1%). The Task Force determined that patients with an active cardiac condition (American Heart Association class I condition-high risk), including unstable or severe angina, recent myocardial infarction, decompensated heart failure, significant arrhythmias, or severe valvular disease should undergo preoperative stress testing. 1 Additionally, patients with no active cardiac conditions who are undergoing vascular or intermediate-risk surgery, with at least 1 clinical risk factor (American Heart Association class II condition) and a functional capacity of 4 metabolic equivalents or less (assessed by activities of daily living), may require cardiac stress testing if the testing will change management. The presence of multiple minor risk factors [eg, advanced age, abnormal electrocardiography, uncontrolled systemic hypertension] might lead to a higher suspicion of coronary artery disease, but is not incorporated into the recommendations for testing. Finally, stress testing is not recommended in the following groups: patients who require emergency noncardiac surgery, patients with no active cardiac conditions (American Heart Association class I conditions) or clinical risk factors (American Heart Association class II conditions) who are undergoing intermediate-risk surgery, patients with no active cardiac conditions (American Heart Association class I conditions) who are undergoing low-risk surgery, and asymptomatic patients with a functional capacity of 4 metabolic equivalents or more. 1 In the 1996 and 2002 American College of Cardiology/American Heart Association guidelines, the recommendations for patients without active cardiac conditions or clinical risk factors (American Heart Association classes I and II) were similar to the 2007 guidelines. 5, 6 Patterns of cardiac stress testing before surgical procedures have not been systematically studied in older adults. The objectives of our study were to determine the frequency of cardiac stress testing before elective noncardiac surgery in a sample of Medicare beneficiaries with no identifiable cardiac risk factors (American Heart Association class I or II conditions), and to determine predictors for the overutilization of preoperative stress testing in this population. We identified preoperative stress tests in Medicare beneficiaries who underwent elective, inpatient surgical procedures (cholecystectomy, colectomy, pancreatectomy, mastectomy, radical prostatectomy, transurethral resection of the prostate, radical nephrectomy, back surgery, knee replacement, hip replacement) between 1996 and 2008 who did not have active cardiac conditions or clinical risk factors (American Heart Association class I or II conditions) based on the American College of Cardiology/American Heart Association guidelines. We evaluated time trends in cardiac stress testing and identified patient, hospital, and area characteristics that predicted the utilization of preoperative stress testing. From this cohort, we identified a subset of patients with no active cardiac conditions or clinical risk factors in the year before surgery (see list of conditions in Table 1 ). In addition to these diagnoses, we excluded patients who had undergone coronary artery bypass grafting, coronary angioplasty, coronary stent placement, or cardiac catheterization in the year before the elective noncardiac surgery. With these exclusions, the final sample size of the cohort was 74,785.
METHODS

Data Source
Definition of Stress Test
We identified patients who had a stress test in the 2 months before elective noncardiac surgery. Stress tests were identified using the Common Procedure Terminology codes for stress echocardiography (93350), exercise via treadmill or pharmacological stress test (93015-93018), and myocardial nuclear imaging (78460-78465, 78472-78496).
Study Variables
Patient demographic characteristics included age at the time of surgery (65-69, 70-74, 75-79, 80-84, 85+ years), sex, and race (white, black, other). Race was obtained from the Medicare denominator file, which uses Social Security Administration demographic data. Patient comorbidities were ascertained using International Classification of Disease-9-Clinical Modification diagnosis and procedure codes from the inpatient and outpatient claims in the year before the date of surgery and classified using the Charlson comorbidity 7, 8 The majority of patients had zero comorbidities; therefore, the comorbidity index was categorized into a dichotomous variable (≥1 versus none).
We classified surgical procedures as "high risk" (colectomy, pancreatectomy, radical prostatectomy, radical nephrectomy), "intermediate risk" (cholecystectomy, back surgery, knee replacement, hip replacement), and "low risk" (mastectomy, transurethral resection of the prostate) based on the risk of morbidity and mortality. The American Heart Association guidelines classify surgical procedures based on incidence of cardiac death and nonfatal myocardial infarction. The American Heart Association categories, in order of decreasing risk are vascular, intermediate risk, and low risk. All of the surgical procedures included in this study are nonvascular and therefore qualify as intermediate-to low-risk surgery in terms of cardiac risk. Diagnosis codes from the surgery admission were used to identify cardiac complications after surgery. A subset of class I and class II cardiac conditions were selected to indicate cardiac complications. These conditions are listed in Table 2 . As described above, the analytical cohort was restricted to patients with no diagnoses for class I or class II cardiac conditions in inpatient or outpatient claims in the year before the date of surgery. Therefore, patients with diagnoses on the surgical claim for any conditions from the subset of class I or class II cardiac conditions (Table 2 ) were considered to have had postoperative cardiac complications. Limitations of this approach are described in the Discussion section. In addition to cardiac complications, we examined 30-day mortality in patients after surgery.
Hospital characteristics included hospital size (number of beds), type (nonprofit, for-profit, government), and medical school affiliation. Cardiologist visits before surgery were identified using Evaluation and Management codes in the Carrier file. The size of the metropolitan statistical area where the hospital was located was categorized as <250,000, 250,000 to 1,000,000, and ≥1,000,000. Each patient was linked to a Dartmouth Atlas hospital referral region based on their zip code of residence. The number of cardiologists per 100,000 persons in the hospital referral region was included as a measure of physician availability using Dartmouth Atlas data. This variable was estimated as the average of the number of cardiologists in the hospital referral region in 1996 and 2006 and stratified into quartiles. Total Medicare reimbursements (Parts A and B) per enrollee in the hospital referral region in the year of surgery were included to measure Medicare expenditures for each hospital referral region. 
Statistical Analysis
Descriptive characteristics were provided for the overall cohort. The rate of stress testing was compared across groups using χ 2 tests. Changes in stress testing over the study period were evaluated using the Cochran-Armitage trend test. 9, 10 The increase in testing over time was not linear; therefore, the year of surgery was included as a categorical variable in multivariate models, with 1996 as the referent group. The rate of testing was also compared across US regions, cardiologist availability in the hospital referral region, and Medicare expenditures in the hospital referral region using χ 2 tests. A generalized estimating equation model with a binomial distribution, logit link, and exchangeable correlation structure was used to identify independent predictors of preoperative cardiac stress testing. Model parameters and standard errors were estimated using generalized estimating equations to account for clustering of patients within hospitals and hospital referral regions. 11 The hospital identifiers nested within the hospital referral region identifier were specified as the cluster-level variables. The sample size for multivariate analyses was 74,117 because 670 patients were unable to be linked to a hospital or a hospital referral region. All other patients had complete covariate data. The final multivariate model included the sex, year of surgery, comorbidity, size of the metropolitan statistical area, risk level of the surgical procedure, US region of residence, hospital bed size, cardiologist availability and Medicare expenditures in the hospital referral region. Models were developed by entering candidate covariates associated with stress testing in bivariate analyses into the model. Variables with an adjusted P-value of < 0.10 were retained in the multivariate model. Model fit was assessed using the "quasi-likelihood under the independence criterion 12 ;" a lower quasilikelihood under the independence criterion value indicates a better model fit. A P-value of < 0.05 was considered statistically significant for all analyses. SAS 9.2 statistical software (SPSS Inc., Cary, NC) was used for data management and statistical analysis.
RESULTS
A total of 211,202 patients undergoing elective noncardiac, nonvascular surgery from 1996 to 2008 were identified from 259,632 Medicare operative claims. Of these patients, 74,785 had no diagnoses consistent with cardiac conditions (Table 1 ) in the year before surgery. The overall study cohort is described in Table 3 . Patients undergoing elective surgery with no cardiac indications for stress testing were mostly female (60.3%) and mostly white (93.1%). Fiftynine percent of the patients were aged 65 to 74 years. The majority of the study cohort had a Charlson comorbidity score of zero (88.1%). Most patients in the cohort were undergoing intermediaterisk surgery (64.3%), with a smaller portion of patients undergoing high-risk (18.9%) or low-risk (16.8%) procedures. Only 2.23% of patients had cardiac complications, and 0.53% died within 30 days of surgery. The majority of patients underwent surgery in nonprofit hospitals and hospitals with no medical school affiliation.
Out of 74,785 patients with no indications for stress testing, 2803 (3.75%) received stress tests in the 2 months before surgery. The median time interval between testing and surgery was 13 days. Only 31% of patients who underwent stress testing visited a cardiologist before testing. stress testing was higher for females (4.07%) than for males (3.26%, P < 0.0001). Patients with a Charlson comorbidity score of ≥ 1 had higher rates of stress testing (4.39%) than patients with a Charlson comorbidity of zero (3.66%, P = 0.001). The risk of the surgical procedure also impacted the rate of stress testing. Patients who underwent high-risk procedures had higher rates of stress testing (4.30%) than patients undergoing low-risk procedures (1.57%, P < 0.0001). The rate of preoperative stress testing was higher in patients with postoperative cardiac complications (5.22%) compared with patients without cardiac complications (3.70%, P = 0.001), but there was no difference in stress testing by 30-day mortality (P = 0.430).
Patients from a medical service area with more than 1 million people were more likely to receive stress testing (4.41%) than patients from a medical service area with 250,000 to 1 million (3.37%) or less than 250,000 people (2.90%, P < 0.0001). Patients who underwent surgery in a hospital affiliated with a medical school were more likely to receive stress testing (4.11%) compared with those who underwent surgery in a hospital with no medical school affiliation (3.52%, P < 0.0001). Additionally, nonprofit hospitals had higher rates of testing (3.90%) compared with for-profit (3.17%) and government hospitals (3.30%) (P = 0.0002). Hospital size was also associated with the rates of stress testing. Hospitals with more than 500 beds had higher rates of testing compared with smaller hospitals (P < 0.0001) ( Table 4) .
There were significant temporal trends in the rate of stress testing, with an increase from 1.72% in 1996 to 6.44% in 2007 ( Fig. 1 ; P < 0.0001). Following the 2007 American College of Cardiology/American Heart Association guidelines, the use of stress testing declined by 0.89 to 5.55% in 2008 (P = 0.064; Fig. 1 ). There was geographical variation in the use of stress testing, with rates ranging from 2.70% in the Pacific West to 4.68% in the Midwest. In addition, patients living in areas with more cardiologists per 100,000 people were also more likely to undergo preoperative stress testing (P < 0.0001), with rates ranging from 4.42% in the highest quartile to 3.14% in the lowest quartile. Stress testing rates were positively correlated with Medicare expenditures, with higher rates of testing in patients from areas with the highest expenditures per enrollee (4.35%) compared with areas with the lowest expenditures per enrollee (2.84%, P < 0.0001).
The multivariate model ( 
DISCUSSION Implications
We found that approximately 4% of Medicare patients with no cardiac risk factors had a cardiac stress test in the 2 months before elective noncardiac, nonvascular surgery. These 2803 patients from our 5% national Medicare sample represent more than 56,000 Medicare patients who received unnecessary cardiac stress testing during our study period. We selected a restricted cohort of patients for whom preoperative cardiac stress testing did not appear to be indicated; therefore, our estimates represent an underestimation of Copyright © 2012 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. unnecessary testing. The American College of Cardiology/American Heart Association guidelines also stipulate that cardiac stress testing is not indicated in patients with 1 risk factor and good functional capacity; however, we did not attempt to estimate the use of stress testing in these patients because Medicare data do not include functional capacity. We expect that rates of cardiac stress testing would be higher in such patients. Medicare reimbursement for cardiac stress tests in 2011 ranged from $92.42 for an exercise stress test with an interpretation and report to $341.12 for a myocardial perfusion imaging stress test. 13 Unnecessary stress testing could represent a significant expense to Medicare. Myocardial perfusion imaging (Common Procedure Terminology 78465 during the study period), which includes imaging stress tests, was ranked 14th in the list of Medicare leading Common Procedure Terminology procedure codes in 2009, with more than $978 million in allowable charges.
14 Physicians need to be informed about indications for preoperative stress testing to mitigate costs to the healthcare system and patients. Although testing may be beneficial, there are potential harms. Unnecessary testing may lead to further testing and surgical delay or cancellation. 15 We could not assess surgical delays or cancellations with this dataset, as our cohort was defined by identifying patients undergoing the given surgical procedures. Although evidence on the downstream harm of testing in asymptomatic patients is lacking, it is estimated that 0.6% to 2.9% of asymptomatic patients undergoing exercise stress testing also undergo angiography and 1% undergo cardiac revascularization, despite the risks and lack of proven benefit in asymptomatic patients. [16] [17] [18] [19] In our study, 44 patients (1.6%) underwent angiography or revascularization after stress testing. Such patients are exposed to the potential harms related to these procedures, including bleeding and contrast and radiation exposure. In low-risk patients with no clinical risk factors, preoperative stress testing has not been shown to improve postoperative outcomes.
15,16
Predictors of Stress Testing
We identified several predictors of preoperative stress testing in patients with no cardiac risk factors. Patients with 1 or more comorbidities were significantly more likely to undergo preoperative stress testing. Physicians may be overly cautious and order stress testing during preoperative evaluation for patients with conditions that are not considered to be clinically significant risk factors for perioperative cardiac events. Patients who underwent "high-risk" procedures were also more likely to undergo preoperative stress testing, indicating that physicians order stress tests for procedures with increased risk of morbidity and mortality even in patients with no clinical risk factors for perioperative cardiac events. The American College of Cardiology/American Heart Association guidelines indicate that preoperative stress testing should be reserved for patients with clinically significant risk factors. 1, 15, 16 Minor risk factors such as advanced age, abnormal electrocardiography (left ventricular hypertrophy, left bundle branch block), atrial fibrillation, low functional capacity, and uncontrolled systemic hypertension have not been shown to independently predict perioperative cardiac events. 1, [20] [21] [22] However, there has been little research investigating the impact of combinations of these conditions. The presence of multiple minor risk factors increases suspicion of coronary artery disease but is not incorporated into the American College of Cardiology/American Heart Association testing recommendations.
Our results show somewhat higher rates of stress testing in regions with greater Medicare expenditures and cardiologist availability. This supports previous findings that there is increased diagnostic testing, treatment, and healthcare spending in areas with relatively more medical specialists. 23 Previous research has demonstrated wide regional variation in the utilization of diagnostic testing 24, 25 and treatment, [26] [27] [28] which directly correlates to the regional variability in healthcare spending. 23 One study found that the proportion of Medicare patients who undergo echocardiography in the same year varies as much as 3-fold between states. 29 Our results also showed variation in preoperative stress testing by US region. Regional differences in patient composition may contribute to the variation in cardiac stress testing. The use of cardiac stress testing was significantly lower among patients in the Pacific West. It is possible that patients in this region have lower body mass indexes than those in other regions, which could contribute to some of the regional differences. Unfortunately, body mass indexes are not well captured in Medicare data.
There was a dramatic increase over the study period in the utilization of preoperative cardiac stress testing in patients with no indications for testing. In 1992, only 1% of patients underwent preoperative testing, and this rate increased to 6% in 2007. These results are consistent with previous studies that show increased use of cardiac stress testing in elderly patients over this time period. 30, 31 In the context of rising healthcare costs and public concerns over the federal deficit, this is an alarming trend. On the other hand, our data also showed a slight decline in the use of preoperative cardiac stress testing in 2008. It is unclear whether this finding represents a change in the trend or simply data fluctuations. Shaw et al have also reported that high annual growth rates for echocardiography and myocardial perfusion on single-photon emission computed tomography attenuated after 2005. 32 The change in the trend may reflect the results of efforts by the Centers for Medicare & Medicaid Services and the Government Accountability Office to reduce the growth in Medicare Part B spending on imaging services. 33 The American College of Cardiology/American Heart Association guidelines for perioperative cardiovascular evaluation were revised twice during our study period-in 1996 and in 2002. However, the recommendations for patients without active cardiac conditions and clinical risk factors were similar for each set of guidelines. 1, 5, 6 In 2002, renal insufficiency was added to the list of intermediate risk factors, and in 2007, a history of cerebrovascular disease was determined to be an intermediate risk factor. Patients with these conditions were excluded from our study cohort, so these changes should not have impacted our results.
Strength of the Evidence
The American College of Cardiology/American Heart Association guidelines are developed by the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. In developing the guidelines, the Task Force performs an extensive literature review, weighs the strength of the evidence, and estimates the expected health outcomes where data exist. The guidelines are reviewed annually and updated as appropriate, and as such, they are the best guidelines currently available. Despite this, the American College of Cardiology/American Heart Association guidelines for perioperative evaluation may not apply in all circumstances, and physicians are expected to use their best clinical judgment when making decisions regarding patient care. We were unable to determine whether a stress test for any given patient was appropriate or inappropriate. A variety of clinical circumstances may justify the use of preoperative stress testing, and these circumstances are not always well captured in administrative data.
However, we can provide a description at the population level. The patterns and time trends we observed suggest that physician practice patterns, more than patient clinical characteristics, are driving the use of preoperative testing in patients with no cardiac risk factors. Even after controlling for patient characteristics, there was a sharp increase in use over time in our study. In addition, the use of stress testing was correlated with high Medicare expenditures, with patients living in hospital referral regions with the highest Medicare expenditures having increased odds of undergoing stress testing. As mentioned earlier, other studies evaluating the utilization of stress testing in other settings have shown similar patterns. Regional variations in the rates of stress testing are strongly correlated with rates of coronary angiography and revascularization procedures. 29 
Limitations
We performed a retrospective observational study using administrative data. We excluded patients with diagnostic codes that most closely represented the active cardiac conditions and clinical risk factors defined by the American College of Cardiology/American Heart Association guidelines; 34, 35 however, the codes were generally less specific than the conditions in the guidelines. Additionally, postoperative cardiac events are difficult to capture using administrative data that were not collected for research purposes. The validity of using International Classification of Disease-9 diagnosis codes to identify complications after surgery is uncertain because diagnostic codes fail to distinguish between pre-existing comorbid conditions and acute complications. [36] [37] [38] [39] Investigators have developed screening algorithms to identify hospital complications using discharge data, [38] [39] [40] but these screening methods may still identify cases where the condition was present upon admission rather than occurring inhospital. 38, 40 Nevertheless, some screenings have shown good validity for identifying complications in surgical cases. 38 In our study, we restricted the sample to patients with no diagnoses for cardiac conditions or clinical risk factors. As recommended by Finlayson et al, 37 we used inpatient and outpatient claims before the surgical admission to identify patient comorbidities. We limited our analytical cohort to patients with no diagnoses for cardiac conditions or clinical risk factors in the year before surgery and attempted to identify "incident" cardiac complications based on the presence of diagnoses for cardiac conditions on the surgical claim. Some patients may have had pre-existing cardiac conditions that were not captured by diagnosis codes on inpatient or outpatient visits in the 12 months before surgery; therefore, this approach may have misclassified previously undiagnosed pre-existing conditions as postoperative cardiac complications for some patients. We found that patients who had cardiac complications were more likely to have had a stress test. This may be due to a misclassification of pre-existing conditions as complications or due to an unmeasured selection for stress testing. Patients chosen for stress testing may have had a higher cardiac risk based on factors unmeasured in our study, such as family history, symptoms (chest pain, shortness of breath, etc.), or obesity. However, there is no strong evidence, nor can we conclude from our study that preoperative stress testing reduced complications in this group of patients.
Although we were able to describe trends and identify independent predictors of stress testing in patients with no clinical risk factors, our results may be limited by patient selection bias, which may influence the likelihood of undergoing surgery as well as receiving stress testing preoperatively. Another study limitation is that our sample excluded, by design, patients who underwent preoperative testing and, on the basis of their stress test results, did not have surgery or underwent coronary angiography or coronary revascularization. We chose a 2-month time frame to identify stress tests that were likely ordered as part of a preoperative cardiac evaluation, rather than other indications such as chest pain. The rate of preoperative stress testing was similar (4.1%) in sensitivity analyses using a 90-day window. Finally, the absolute numbers of potentially unnecessary preoperative tests are low, corresponding to approximately 4667 tests per year in the national population of Medicare patients undergoing elective noncardiac, nonvascular surgery with no cardiac risk factors.
CONCLUSIONS
This study provided a description of the overutilization of preoperative cardiac stress testing in Medicare patients who underwent elective noncardiac, nonvascular surgery. We excluded from the sample patients with any cardiac conditions or clinical risk factors. Our results represent a conservative estimate of overutilization. Approximately 4% of patients received a stress test when it was not indicated, and the rate of stress testing increased over the study period. Our results indicate that the inappropriate use of preoperative cardiac stress testing is a strong area for additional investigation and direct clinical validation using better sources of data. Our study specifically looks at the overuse in a very carefully selected cohort of patients with no cardiac comorbidities. Further studies can evaluate inappropriate use, including potential overuse and underuse, in patients with specific risk factors.
